RxDoctor Payments Data

Prema Peethambaran, MD

Medical Oncology · Rochester, MNNPI 1760460505

Payments from drug & device makers

$80in general payments, 2019–2025

Across 2 payments — averaging $40.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$68
  • Gilead$12

What the payments were for

  • Education$80100%

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca1$68
Gilead1$12

How this compares

$80 in reported general payments places this provider in the 10th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$928,202
Medicare patients
243
Services billed
28,757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VerzenioAbemaciclib20$327,810
EliquisApixaban13$7,394
XareltoRivaroxaban11$6,138
Letrozole77$1,745
Anastrozole36$1,060
Exemestane12$772
Tamoxifen Citrate27$740
Gabapentin16$432
Ondansetron Hcl21$369
Olanzapine14$246
Prochlorperazine Maleate21$215
Dexamethasone22$163
LoperamideLoperamide Hcl16$147

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →